BORA PHARMACEUTICALS LTD Financial Flexibility Index
BORA PHARMACEUTICALS LTD financial flexibility index. BORA PHARMACEUTICALS LTD (6472) has a Financial Flexibility Index of 0.03x as of March 2026. Free cash flow of NT$779.54 Million (operating CF NT$568.46 Million minus capex NT$211.08 Million) represents 0% of total liabilities (NT$28.70 Billion). See cash generation quality of BORA PHARMACEUTICALS LTD to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BORA PHARMACEUTICALS LTD (2019–2025)
Financial flexibility index of BORA PHARMACEUTICALS LTD from 2019 to 2025. Historical Financial Flexibility Index trend for BORA PHARMACEUTICALS LTD across 7 annual periods. Check BORA PHARMACEUTICALS LTD cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
BORA PHARMACEUTICALS LTD Financial Flexibility Index by Year (2019–2025)
BORA PHARMACEUTICALS LTD financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for BORA PHARMACEUTICALS LTD. For the full cash flow conversion analysis, see cash efficiency ratio of BORA PHARMACEUTICALS LTD.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | NT$5.17 Billion | NT$4.24 Billion | NT$27.24 Billion | ▲ +248.1% |
| 2024 | 0.05x | NT$1.67 Billion | NT$980.81 Million | NT$30.59 Billion | ▼ -88.0% |
| 2023 | 0.45x | NT$6.04 Billion | NT$4.61 Billion | NT$13.29 Billion | ▲ +262.7% |
| 2022 | 0.13x | NT$2.21 Billion | NT$2.01 Billion | NT$17.62 Billion | ▼ -66.9% |
| 2021 | 0.38x | NT$1.60 Billion | NT$1.24 Billion | NT$4.22 Billion | ▲ +421.8% |
| 2020 | 0.07x | NT$329.88 Million | NT$177.79 Million | NT$4.54 Billion | ▼ -86.5% |
| 2019 | 0.54x | NT$929.10 Million | NT$231.77 Million | NT$1.73 Billion | — |